Literature DB >> 32243793

Psychedelic Psychiatry's Brave New World.

David Nutt1, David Erritzoe2, Robin Carhart-Harris2.   

Abstract

After a legally mandated, decades-long global arrest of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding exciting results. Outcomes of neuroscience and clinical research into 5-Hydroxytryptamine 2A (5-HT2A) receptor agonists, such as psilocybin, show promise for addressing a range of serious disorders, including depression and addiction.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32243793     DOI： 10.1016/j.cell.2020.03.020

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  41 in total

Review 1.  The acute effects of classic psychedelics on memory in humans.

Authors:  C J Healy
Journal:  Psychopharmacology (Berl)       Date:  2021-01-09       Impact factor: 4.530

2.  Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor.

Authors:  Kuglae Kim; Tao Che; Ouliana Panova; Jeffrey F DiBerto; Jiankun Lyu; Brian E Krumm; Daniel Wacker; Michael J Robertson; Alpay B Seven; David E Nichols; Brian K Shoichet; Georgios Skiniotis; Bryan L Roth
Journal:  Cell       Date:  2020-09-17       Impact factor: 41.582

Review 3.  The promises and perils of psychedelic pharmacology for psychiatry.

Authors:  Tristan D McClure-Begley; Bryan L Roth
Journal:  Nat Rev Drug Discov       Date:  2022-03-17       Impact factor: 84.694

Review 4.  Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes.

Authors:  Jacopo Sapienza; Marta Bosia; Marco Spangaro; Francesca Martini; Giulia Agostoni; Federica Cuoco; Federica Cocchi; Roberto Cavallaro
Journal:  Mol Psychiatry       Date:  2022-08-05       Impact factor: 13.437

5.  Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder.

Authors:  M J Spriggs; H Kettner; R L Carhart-Harris
Journal:  Eat Weight Disord       Date:  2020-09-08       Impact factor: 4.652

6.  Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.

Authors:  Calvin Ly; Alexandra C Greb; Maxemiliano V Vargas; Whitney C Duim; Ana Cristina G Grodzki; Pamela J Lein; David E Olson
Journal:  ACS Pharmacol Transl Sci       Date:  2020-09-11

Review 7.  On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.

Authors:  Richard J Zeifman; Nikhita Singhal; Leah Breslow; Cory R Weissman
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-11

8.  Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.

Authors:  Keri Mans; Hannes Kettner; David Erritzoe; Eline C H M Haijen; Mendel Kaelen; Robin L Carhart-Harris
Journal:  Front Psychiatry       Date:  2021-06-29       Impact factor: 4.157

9.  Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.

Authors:  Kate Corrigan; Maeve Haran; Conor McCandliss; Roisin McManus; Shannon Cleary; Rebecca Trant; Yazeed Kelly; Kathryn Ledden; Gavin Rush; Veronica O'Keane; John R Kelly
Journal:  Ir J Med Sci       Date:  2021-06-15       Impact factor: 2.089

10.  Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice.

Authors:  Tanishka S Saraf; Daniel E Felsing; Jessica L Armstrong; Raymond G Booth; Clinton E Canal
Journal:  Epilepsy Res       Date:  2021-05-27       Impact factor: 2.991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.